India · Delayed Price · Currency is INR Intra-Cellular Therapies Statistics
Total Valuation
BOM:544274 has a market cap or net worth of INR 1.72 trillion. The enterprise value is 1.65 trillion.
| Market Cap | 1.72T |
| Enterprise Value | 1.65T |
Important Dates
The last earnings date was Monday, July 28, 2025.
| Earnings Date | Jul 28, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 812.54M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +0.00% |
| Shares Change (QoQ) | +0.02% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 142.19M |
Valuation Ratios
The trailing PE ratio is 31.21 and the forward PE ratio is 28.36.
| PE Ratio | 31.21 |
| Forward PE | 28.36 |
| PS Ratio | 2.52 |
| PB Ratio | 10.57 |
| P/TBV Ratio | 10.70 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 29.81 |
| EV / Sales | 2.41 |
| EV / EBITDA | 18.70 |
| EV / EBIT | 24.58 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.05 |
| Debt / EBITDA | 0.10 |
| Debt / FCF | n/a |
| Interest Coverage | 55.65 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 27.79% |
| Return on Capital Employed (ROCE) | n/a |
| Revenue Per Employee | 112.25M |
| Profits Per Employee | 9.08M |
| Employee Count | 6,081 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, BOM:544274 has paid 19.15 billion in taxes.
| Income Tax | 19.15B |
| Effective Tax Rate | 25.76% |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 2,059.78 |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 51.07 |
| Average Volume (20 Days) | 21,158 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BOM:544274 had revenue of INR 682.62 billion and earned 55.20 billion in profits. Earnings per share was 67.93.
| Revenue | 682.62B |
| Gross Profit | 191.95B |
| Operating Income | 66.94B |
| Pretax Income | 74.35B |
| Net Income | 55.20B |
| EBITDA | 87.87B |
| EBIT | 66.94B |
| Earnings Per Share (EPS) | 67.93 |
Balance Sheet
The company has 85.79 billion in cash and 8.50 billion in debt, giving a net cash position of 77.29 billion.
| Cash & Cash Equivalents | 85.79B |
| Total Debt | 8.50B |
| Net Cash | 77.29B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 162.96B |
| Book Value Per Share | 200.58 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 28.12%, with operating and profit margins of 9.81% and 8.09%.
| Gross Margin | 28.12% |
| Operating Margin | 9.81% |
| Pretax Margin | 10.89% |
| Profit Margin | 8.09% |
| EBITDA Margin | 12.87% |
| EBIT Margin | 9.81% |
| FCF Margin | n/a |
Dividends & Yields
BOM:544274 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.00% |
| Shareholder Yield | n/a |
| Earnings Yield | 3.20% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |